Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Brett Doble, Marcus Tan, Anthony Harris & Paula Lorgelly. (2015) Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist. Expert Review of Molecular Diagnostics 15:2, pages 235-254.
Read now
Read now
Articles from other publishers (13)
Luiza R. Grazziotin, Bukky R. Dada, Carolina de la Rosa Jaimes, Winson Y. Cheung & Deborah A. Marshall. (2020) Chromogenic and Silver in Situ Hybridization for Identification of HER 2 Overexpression in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Applied Immunohistochemistry & Molecular Morphology 28:6, pages 411-421.
Crossref
Crossref
Aziza Nassar, Advani Pooja & Mamatha Chivukula. (2020) HER2 testing across practices—Have we come to a consensus on the ideal method of testing? A systematic literature review. The Breast Journal 26:6, pages 1185-1188.
Crossref
Crossref
Yan‐Xing Guan, Meng‐zhi Zhang, Xue‐Zhong Chen, Qing Zhang, Shao‐Zheng Liu & Yong‐Lu Zhang. (2018) Lnc RNA SNHG20 participated in proliferation, invasion, and migration of breast cancer cells via miR‐495. Journal of Cellular Biochemistry 119:10, pages 7971-7981.
Crossref
Crossref
Virginie Nerich, Sopany Saing, Eva Maria Gamper, Georg Kemmler, Franck Daval, Xavier Pivot & Bernhard Holzner. (2016) Cost–utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Research and Treatment 159:3, pages 407-424.
Crossref
Crossref
Marie-Pierre Chenard, Marie-Pierre Wissler, Noëlle Weingertner, Carole Mathelin & Jean-Pierre Bellocq. (2015) HER2 gene and protein expression status of breast carcinoma can be reliably tested on a single slide. Virchows Archiv 467:2, pages 169-175.
Crossref
Crossref
Louis P. GarrisonJr.Jr., Joseph B. Babigumira, Anthony Masaquel, Bruce C.M. Wang, Deepa Lalla & Melissa Brammer. (2015) The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer. Value in Health 18:4, pages 541-546.
Crossref
Crossref
Lucia Zanatta, Laura Valori, Eleonora Cappelletto, Maria Elena Pozzebon, Elisabetta Pavan, Angelo Paolo Dei Tos & Dennis Merkle. (2015) Reagent and Labor Cost Optimization through Automation of Fluorescence In Situ Hybridization (FISH) with the VP 2000: An Italian Case Study. SLAS Technology 20:1, pages 25-31.
Crossref
Crossref
Ilaria Pennacchia, Fabio M. Vecchio, Arnaldo Carbone & Vincenzo Arena. (2015) HER2 Immunohistochemical Assessment With A0485 Polyclonal Antibody. Applied Immunohistochemistry & Molecular Morphology 23:1, pages 31-35.
Crossref
Crossref
Karen Zwaenepoel, Amber Van Dongen, Suzan Lambin, Christine Weyn & Patrick Pauwels. (2014)
Detection of ALK expression in non-small-cell lung cancer with
ALK
gene rearrangements - comparison of multiple immunohistochemical methods
. Histopathology 65:4, pages 539-548.
Crossref
Crossref
Julian C. Schink, Julia R. Trosman, Christine B. Weldon, Kalliopi P. Siziopikou, Gregory J. Tsongalis, Alfred W. Rademaker, Jyoti D. Patel, Al B. BensonIIIIII, Edith A. Perez & William J. Gradishar. (2014) Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers. JNCI: Journal of the National Cancer Institute 106:10.
Crossref
Crossref
Julia R Trosman, Christine B Weldon, Julian C Schink, William J Gradishar & Al B Benson. (2013)
What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of
HER2
/
Neu
testing in breast cancer
. Journal of Comparative Effectiveness Research 2:4, pages 461-477.
Crossref
Crossref
Leandro Lindner, Ana Vieta, César Rodríguez, Agustí Barnadas, Pedro Sánchez-Rovira & Iker Martín. (2013) Análisis coste-efectividad de la terapia adyuvante con trastuzumab para el tratamiento de cáncer de mama en estadios iniciales. PharmacoEconomics Spanish Research Articles 10:1, pages 27-35.
Crossref
Crossref
Hiroaki Nitta, Brian D Kelly, Mary Padilla, Nikolaus Wick, Patrick Brunhoeber, Isaac Bai, Shalini Singh, Jim Ranger-Moore, Chris Bieniarz, Hitoshi Tsuda & Thomas M Grogan. (2012) A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections. Diagnostic Pathology 7:1.
Crossref
Crossref